DOCSLIB.ORG

The Role of Peptidyl Arginine Deiminase, Type IV (PAD4) in the Pathology of Shock/Sepsis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Role of Peptidyl Arginine Deiminase, Type IV (PAD4) in the Pathology of Shock/Sepsis The Role of Peptidyl arginine deiminase, type IV (PAD4) in the Pathology of Shock/Sepsis By Bethany Marie Biron B.A., Worcester State College M.S., Johns Hopkins University Dissertation Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Division of Biology and Medicine at Brown University Providence RI May 2017 © Copyright 2017 by Bethany M. Biron This dissertation by Bethany Marie Biron is accepted in its present form by the Department of Pathobiology as satisfying the dissertation requirement for the degree of Doctor of Philosophy. Date_____________ _________________________________ Alfred Ayala, Co-Advisor Date_____________ _________________________________ Jonathan Reichner, Co-Advisor Advisor Recommended to the Graduate Council Date_____________ _________________________________ Craig Lefort, Reader Date_____________ _________________________________ Daithi Heffernan, Reader Date_____________ _________________________________ Bruce Levy, Outside Reader Approved by the Graduate Council Date_____________ _________________________________ Andrew Campbell, Dean of the Graduate School i Bethany M. Biron Girard, BA, MS Pathobiology Graduate Program-Pre-doctoral Student Co-Mentored by Alfred Ayala/Jonathan Reichner Division of Surgical Research Rhode Island Hospital Brown Medical School Aldrich 239, 593 Eddy Street Providence, RI 02903 Email: [email protected] Primary Research Field My current research involves studying the citrullination of histones via Protein Arginine Deiminase 4 (PAD4) and its involvement in Neutrophil Extracellular trap formation in disease states. Acute lung injury (ALI) is a common sequela of shock/trauma and is associated with significant mortality. Trauma patients exposed to a secondary infectious challenge are considered at significant risk for inflammatory lung injury. Neutrophil extracellular traps (NETs) are capable of microbial killing essential for combating systemic infection, but are also associated with detrimental inflammation in the host. My research entails defining the role of NET formation in the protection of the host from indirect acute lung injury as a result of hemorrhage and subsequent septic challenge, as well as elucidates the importance of NETs to host defense and whether the host is benefited or harmed by NET release by using an array of basic science laboratory protocols and methods.. Education 2013-present Ph.D. Pending. Pathobiology, Brown University, Providence, RI 2011 M.S. in Biotechnology concentration Biodefense, Johns Hopkins University, Rockville MD. 2007 B.A. in Spanish and Natural Sciences, Worcester State College, Worcester, MA Professional Experience Aug 2009- Aug2012 Research Microbiologist, Center for Aerobiological Sciences, USAMRIID, Frederick, MD I participated in GLP and non-GLP infectious disease vaccine research and aerosol model development research experiments in BSL-3 laboratory environments. Under the supervision of the division chief for Aerobiological Sciences I developed, wrote, and carried out animal protocols in accordance to IACUC standards. More specifically I was in charge of developing and executing adjunct therapy studies against inhalational anthrax infection. In addition, I performed aerosolization of bacterial and viral agents in a class III biosafety cabinet, and then employed various biological techniques to determine aerosol concentrations of biological agents as well as ii for protein quantization, antibody assays, and tissue culture assays. Upon completion of studies I analyzed data and wrote scientific reports and papers for publication. Completed all background checks and obtained top secret clearance to perform duties in BSL 3-4 laboratories, as well as enrolled in Personal Reliability Program (PRP) for work with select agents. Oct 2007- Aug 2009 Research Laboratory Technician II, Charles River Labs, Shrewsbury, MA I served as lead/primary technician for multiple basic and complex in-life studies simultaneously. This included generating data with minimal supervision in the performance of studies as well as being responsible for handling and restraining animals, clinical observations, sample collections, monitoring food consumption, animal husbandry, and performing accurate data collection and reporting. Specialized in small animal procedures and worked in compliance with Good Laboratory Practice Regulations (GLP’s), study protocols, and Standard Operation Procedures (SOP’s) Awards, Honors, Fellowships, Grants: Phi Eta Sigma National Honor Society, 2004 Johns Hopkins University Research Fellowship, USAMRIID, 2009-2011 Shock Society-Travel Award to support presentation of a Poster/Abstract as a part of the 38th Annual Conference on Shock in Denver, CO, June 6-9, 2015 Society for Leukocyte Biology – Travel award to support presentation of Poster/Abstract as part of the 49th Annual SLB Meeting in Verona Italy, Sep 15-18, 2016 Societies: SHOCK Society: Student member Society of Leukocyte Biology: Student member American Society for Investigative Pathology: Graduate student member Publications: Biron BM, Beck K, Dyer D, Mattix M, Twenhafel N, Nalca A. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Antimicrob. Agents Chemother. 59(4):2206-14, 2015. Biron BM, Ayala A, Lomas-Neira JL. Biomarkers for Sepsis: What Is and What Might Be? Biomark. Insights 15;10(Suppl 4):7-17, 2015 (review). Cheng T, Bai J, Chung CS, Chen, Y, Biron BM, Ayala, A. Enhanced innate inflammation induced by anti-BTLA antibody in dual insult model of hemorrhagic shock/sepsis. Shock 45:40-49, 2016 Biron BM, Chen Y, Pulido S, Chung CS, Reichner J, Ayala A. Cl-amidine Prevents Histone 3 Citrullination/NET Formation and Improves Survival in a Murine Sepsis Model. J. Innate Immun. Sep 14, 2016. (Epub ahead of print) iii O’Brian X, Biron BM, Reichner J. Consequences of Extracellular Trap Formation in Sepsis. Current Opinions in Hematology. (in press), 2016 (review) Abstracts (published): Biron BM, Chen Y, Pulido S, Chung CS, Reichner J, Ayala A. The role of PAD4 histone 3 citrullination and net formation in a murine polymicrobial sepsis model. Shock 43:49 (supplt), 2015. Biron BM, Chung C-S, Heffernan DS, Ayala A. 2016. Citrullinated histone modification and NET production is increased the septic patients. Shock 45: supplement 1, 2016 Bethany Biron Girard, Chun-Shiang Chung, Yaping Chen , Jonathan Reichner, Alfred Ayala. Do NETs Matter? Establishing a Role for Neutrophil Extracellular Traps in Patho- Biology of Indirect Acute Lung Injury. Inflammation, Immunity and Cancer: Neutrophils and Other Leukocytes, Verona Italy, 2016 Bethany Biron Girard, Yaping Chen, Chun-Shiang Chung, Jonathan Reichner, Alfred Ayala. PAD4 Deficiency Limits Kidney Dysregulation in a Murine Model of Shock/Sepsis. Experimental Biology, Chicago Il, 2017 Presentations (Oral & Poster): Bethany Biron Girard, Yaping Chen, Chun-Shiang Chung, Jonathan Reichner, Alfred Ayala. PAD4 Deficiency Limits Kidney Dysregulation in a Murine Model of Shock/Sepsis. Experimental Biology/ASIP, Chicago IL (2017) Bethany Biron Girard, Chun-Shiang Chung, Yaping Chen, Jonathan Reichner, Alfred Ayala. Do NETs Matter? Establishing a Role for Neutrophil Extracellular Traps in Patho- Biology of Sepsis and Indirect Acute Lung Injury. Brown University-Graduate Pathobiology Retreat, East Providence, RI (2016) Biron BM, Chen Y, Chung CS, Reichner J, Ayala A. Cl-amidine Prevents Histone 3 Citrullination and Improves Survival in a Murine Sepsis Model. 23rd Annual Hospital Research Celebration, Providence, RI (2015). Biron BM, Chen Y, Chung CS, Reichner J, Ayala A. Cl-amidine Prevents Histone 3 Citrullination and Improves Survival in a Murine Sepsis Model. Brown University- Graduate Pathobiology Retreat, West Greenwich, RI (2015). Biron BM, Chen Y, Pulido S, Chung CS, Reichner J, Ayala A. The Role of Peptidylarginine Deiminase 4 Catalyzed Histone 3 Citrullination and NET formation in Murine Polymicrobial Sepsis Model. 22nd Annual Hospital Research Celebration, Providence, RI (2014). iv Biron BM, Chen Y, Pulido S, Chung CS, Reichner J, Ayala A. The Role of Peptidylarginine Deiminase 4 Catalyzed Histone 3 Citrullination and NET formation in Murine Polymicrobial Sepsis Model. Brown University-Graduate Pathobiology Retreat, Bristol, RI (2014). Biron BM, Chung CS, Ayala A. Expression of Soluble PD-L1 in a Mouse Model of Polymicrobial Sepsis. Brown University-Graduate Pathobiology Retreat, Bristol, RI (2013). Biron BM, Dyer D, Pitt ML. Development of a New Zealand White Rabbit Partial Survival Model for Inhalational Anthrax to Demonstrate Added Value of Adjunct Therapies, Aerobiology in Biodefense IV, Richmond VA (2011) Biron BM, Dyer D, Pitt, ML. Indication Markers for the Treatment of Pneumonic Plague in African Green Monkeys, JHU research symposium, Rockville MD (2011); Ft Detrick Spring Research Festival, Frederick MD (2011) Biron BM, Dyer D, Pitt ML. Comparison of Inhalational Anthrax in African Green Monkeys, Rhesus Macaques, and Cynomologous Macaques. JHU research symposium , Rockville MD (2010); Ft. Detrick Spring Research festival, Frederick MD (2010) Teaching Experience Fall 2013: Teaching Assistant for Dr. Peter Shank PhD. Biology of AIDS, Brown University, Providence RI v ACKNOWLEDGEMENTS The journey to this point has been long and winding with many ups as well as downs. I could not have made it this far without the support system I have. To my mom: I feel like
Load more

Recommended publications
  • Supplemental Methods
    Supplemental Methods: Sample Collection Duplicate surface samples were collected from the Amazon River plume aboard the R/V Knorr in June 2010 (4 52.71’N, 51 21.59’W) during a period of high river discharge. The collection site (Station 10, 4° 52.71’N, 51° 21.59’W; S = 21.0; T = 29.6°C), located ~ 500 Km to the north of the Amazon River mouth, was characterized by the presence of coastal diatoms in the top 8 m of the water column. Sampling was conducted between 0700 and 0900 local time by gently impeller pumping (modified Rule 1800 submersible sump pump) surface water through 10 m of tygon tubing (3 cm) to the ship's deck where it then flowed through a 156 µm mesh into 20 L carboys. In the lab, cells were partitioned into two size fractions by sequential filtration (using a Masterflex peristaltic pump) of the pre-filtered seawater through a 2.0 µm pore-size, 142 mm diameter polycarbonate (PCTE) membrane filter (Sterlitech Corporation, Kent, CWA) and a 0.22 µm pore-size, 142 mm diameter Supor membrane filter (Pall, Port Washington, NY). Metagenomic and non-selective metatranscriptomic analyses were conducted on both pore-size filters; poly(A)-selected (eukaryote-dominated) metatranscriptomic analyses were conducted only on the larger pore-size filter (2.0 µm pore-size). All filters were immediately submerged in RNAlater (Applied Biosystems, Austin, TX) in sterile 50 mL conical tubes, incubated at room temperature overnight and then stored at -80oC until extraction. Filtration and stabilization of each sample was completed within 30 min of water collection.
    [Show full text]
  • Chemical Transformations Encoded by a Gene Cluster in Streptomyces Coelicolor Containing an Unusual Gtp Cyclohydrolase
    Chemical Transformations Encoded by a Streptomyces coelicolor Gene Cluster with an Unusual GTP Cyclohydrolase Item Type text; Electronic Dissertation Authors Spoonamore, James Edward Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 11/10/2021 06:44:52 Link to Item http://hdl.handle.net/10150/194825 CHEMICAL TRANSFORMATIONS ENCODED BY A GENE CLUSTER IN STREPTOMYCES COELICOLOR CONTAINING AN UNUSUAL GTP CYCLOHYDROLASE by James Edward Spoonamore ______________________________ A Dissertation Submitted to the Faculty of the DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOPHYSICS In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY In the Graduate College THE UNIVERSITY OF ARIZONA 2008 2 THE UNIVERSITY OF ARIZONA GRADUATE COLLEGE As members of the Dissertation Committee, we certify that we have read the dissertation prepared by James Edward Spoonamore entitled Chemical Transformations Encoded by a Gene Cluster in Streptomyces coelicolor Containing an Unusual GTP Cyclohydrolase and recommend that it be accepted as fulfilling the dissertation requirement for the Degree of Doctor of Philosophy _______________________________________________________________________ Date: April 16, 2008 Vahe Bandarian _______________________________________________________________________
    [Show full text]
  • SUPPLEMENTARY TEXT. Systems Analysis with the Gaggle Mrna
    SUPPLEMENTARY TEXT. Systems analysis with the Gaggle mRNA level changes were analyzed simultaneously with gene/protein functional associations [operons (Moreno-Hagelsieb and Collado-Vides 2002), phylogenetic profile (Pellegrini et al. 1999), chromosomal proximity (Overbeek et al. 1999)], physical interactions [protein-DNA interactions (Facciotti etal, submitted)], putative functions in the SBEAMS database (http://halo.systemsbiology.net) (Bonneau et al. 2004) along with supporting evidence such as matches in protein databank [PDB (Sussman et al. 1998)], protein families [Pfam (Bateman et al. 2000), COG database (Tatusov et al. 2000)] and metabolic pathways [KEGG (Kanehisa 2002)]. Further, data were extracted into sub- matrices using custom filters, normalized and statistically analyzed using the R statistical package (http://www.r-project.org) and TIGR microarray expression viewer [TMeV (Saeed et al. 2003)]. Given the size and heterogeneity of data and software, we used the Gaggle framework (http://gaggle.systemsbiology.net) (Shannon et al, accepted in BMC Bioinformatics) to facilitate analyses and queries. The Gaggle is an open source Java software framework for seamless desktop integration of diverse databases and software applications. Specifically, all genes were visualized in Cytoscape (Shannon et al. 2003) as networks of nodes (genes) and edges (functional associations). The genes were organized into various function categories and node color was mapped to mRNA level changes (red for increased and green for decreased mRNA) (Johnson etal, submitted, Shannon etal, submitted); and node size was mapped to statistical significance (λ) (Baliga et al. 2004; Shannon et al. 2003). With this visualization scheme significant changes (genes appearing as large red or green nodes) in various function categories become immediately evident.
    [Show full text]
  • Cat# CRE-02 Creatininase Size: 50 Mu Life Technologies (India) Pvt. Ltd
    Product Specification Sheet Cat# CRE-02 Creatininase Size: 50 mU General Information creatininase (EC 3.5.2.10; Creatinine amidohydrolase; CAS# 90285-13-2; EINECS# 232-768-8; ~275 aa depending upon the species; ) is an enzyme that catalyzes the chemical reaction creatinine + H2O creatine Thus, the two substrates of this enzyme are creatinine and H2O, whereas its product is creatine. This enzyme belongs to the family of hydrolases, those acting on carbon-nitrogen bonds other than peptide bonds, specifically in cyclic amides. The systematic name of this enzyme class is creatinine amidohydrolase. This enzyme is also called creatinine hydrolase. This enzyme participates in arginine and proline metabolism. Source: Creatininase is an enzyme that is produced in E. Coli using recombinant DNA technology. It is supplied in powder form with no additives or preservatives. The product is supplied on enzyme activity (KU; The amount of enzyme which produces 1 umol of creatine per min at 37oC and pH 6.5. The final enzyme preparation contains minimal amounts of the relevant contaminants (<1.0 of catalase). The activity is >~500 U/mg material. Storage and Usage Store powder at -20oC or below under dry conditions. Allow the product to reach room temp before opening the vial and dissolve in appropriate buffers for usage. Before returning to storage, re-dessicate under vaccumn over silica gel for a minimum of 4 hours to provide best conditions for long term preservation of enzyme activity. References Starkenburg SR (2006) Appl Environ. Microbiol. 72, 2050 CRE-02 90603A Alpha Diagnostic Intl Inc., 6203 Woodlake Center Dr, San Antonio, TX 78244, USA; India Contact: Life Technologies (India) Pvt.
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]
  • 12) United States Patent (10
    US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,561,811 B2 Bluchel Et Al
    USOO8561811 B2 (12) United States Patent (10) Patent No.: US 8,561,811 B2 Bluchel et al. (45) Date of Patent: Oct. 22, 2013 (54) SUBSTRATE FOR IMMOBILIZING (56) References Cited FUNCTIONAL SUBSTANCES AND METHOD FOR PREPARING THE SAME U.S. PATENT DOCUMENTS 3,952,053 A 4, 1976 Brown, Jr. et al. (71) Applicants: Christian Gert Bluchel, Singapore 4.415,663 A 1 1/1983 Symon et al. (SG); Yanmei Wang, Singapore (SG) 4,576,928 A 3, 1986 Tani et al. 4.915,839 A 4, 1990 Marinaccio et al. (72) Inventors: Christian Gert Bluchel, Singapore 6,946,527 B2 9, 2005 Lemke et al. (SG); Yanmei Wang, Singapore (SG) FOREIGN PATENT DOCUMENTS (73) Assignee: Temasek Polytechnic, Singapore (SG) CN 101596422 A 12/2009 JP 2253813 A 10, 1990 (*) Notice: Subject to any disclaimer, the term of this JP 2258006 A 10, 1990 patent is extended or adjusted under 35 WO O2O2585 A2 1, 2002 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS (21) Appl. No.: 13/837,254 Inaternational Search Report for PCT/SG2011/000069 mailing date (22) Filed: Mar 15, 2013 of Apr. 12, 2011. Suen, Shing-Yi, et al. “Comparison of Ligand Density and Protein (65) Prior Publication Data Adsorption on Dye Affinity Membranes Using Difference Spacer Arms'. Separation Science and Technology, 35:1 (2000), pp. 69-87. US 2013/0210111A1 Aug. 15, 2013 Related U.S. Application Data Primary Examiner — Chester Barry (62) Division of application No. 13/580,055, filed as (74) Attorney, Agent, or Firm — Cantor Colburn LLP application No.
    [Show full text]
  • Functional Equivalence and Evolutionary Convergence PNAS PLUS in Complex Communities of Microbial Sponge Symbionts
    Functional equivalence and evolutionary convergence PNAS PLUS in complex communities of microbial sponge symbionts Lu Fana,b, David Reynoldsa,b, Michael Liua,b, Manuel Starkc,d, Staffan Kjelleberga,b,e, Nicole S. Websterf, and Torsten Thomasa,b,1 aSchool of Biotechnology and Biomolecular Sciences and bCentre for Marine Bio-Innovation, University of New South Wales, Sydney, New South Wales 2052, Australia; cInstitute of Molecular Life Sciences and dSwiss Institute of Bioinformatics, University of Zurich, 8057 Zurich, Switzerland; eSingapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Republic of Singapore; and fAustralian Institute of Marine Science, Townsville, Queensland 4810, Australia Edited by W. Ford Doolittle, Dalhousie University, Halifax, NS, Canada, and approved May 21, 2012 (received for review February 24, 2012) Microorganisms often form symbiotic relationships with eukar- ties (11, 12). Symbionts also can be transmitted vertically through yotes, and the complexity of these relationships can range from reproductive cells and larvae, as has been demonstrated in those with one single dominant symbiont to associations with sponges (13, 14), insects (15), ascidians (16), bivalves (17), and hundreds of symbiont species. Microbial symbionts occupying various other animals (18). Vertical transmission generally leads equivalent niches in different eukaryotic hosts may share func- to microbial communities with limited variation in taxonomy and tional aspects, and convergent genome evolution has been function among host individuals. reported for simple symbiont systems in insects. However, for Niches with similar selections may exist in phylogenetically complex symbiont communities, it is largely unknown how prev- divergent hosts that lead comparable lifestyles or have similar alent functional equivalence is and whether equivalent functions physiological properties.
    [Show full text]
  • POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii
    POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii http://rcin.org.pl WSKAZÓWKI DLA AUTORÓW Kwartalnik „Postępy Biochemii” publikuje artykuły monograficzne omawiające wąskie tematy, oraz artykuły przeglądowe referujące szersze zagadnienia z biochemii i nauk pokrewnych. Artykuły pierwszego typu winny w sposób syntetyczny omawiać wybrany temat na podstawie możliwie pełnego piśmiennictwa z kilku ostatnich lat, a artykuły drugiego typu na podstawie piśmiennictwa z ostatnich dwu lat. Objętość takich artykułów nie powinna przekraczać 25 stron maszynopisu (nie licząc ilustracji i piśmiennictwa). Kwartalnik publikuje także artykuły typu minireviews, do 10 stron maszynopisu, z dziedziny zainteresowań autora, opracowane na podstawie najnow­ szego piśmiennictwa, wystarczającego dla zilustrowania problemu. Ponadto kwartalnik publikuje krótkie noty, do 5 stron maszynopisu, informujące o nowych, interesujących osiągnięciach biochemii i nauk pokrewnych, oraz noty przybliżające historię badań w zakresie różnych dziedzin biochemii. Przekazanie artykułu do Redakcji jest równoznaczne z oświadczeniem, że nadesłana praca nie była i nie będzie publikowana w innym czasopiśmie, jeżeli zostanie ogłoszona w „Postępach Biochemii”. Autorzy artykułu odpowiadają za prawidłowość i ścisłość podanych informacji. Autorów obowiązuje korekta autorska. Koszty zmian tekstu w korekcie (poza poprawieniem błędów drukarskich) ponoszą autorzy. Artykuły honoruje się według obowiązujących stawek. Autorzy otrzymują bezpłatnie 25 odbitek swego artykułu; zamówienia na dodatkowe odbitki (płatne) należy zgłosić pisemnie odsyłając pracę po korekcie autorskiej. Redakcja prosi autorów o przestrzeganie następujących wskazówek: Forma maszynopisu: maszynopis pracy i wszelkie załączniki należy nadsyłać w dwu egzem­ plarzach. Maszynopis powinien być napisany jednostronnie, z podwójną interlinią, z marginesem ok. 4 cm po lewej i ok. 1 cm po prawej stronie; nie może zawierać więcej niż 60 znaków w jednym wierszu nie więcej niż 30 wierszy na stronie zgodnie z Normą Polską.
    [Show full text]
  • Jitonnom, J., Mujika, JI, Van Der Kamp, MW, & Mulholland, AJ (2017)
    Jitonnom, J., Mujika, J. I., van der Kamp, M. W., & Mulholland, A. J. (2017). Quantum mechanics/molecular mechanics simulations identify the ring-opening mechanism of creatininase. Biochemistry, 56(48), 6377-6388. https://doi.org/10.1021/acs.biochem.7b01032 Peer reviewed version Link to published version (if available): 10.1021/acs.biochem.7b01032 Link to publication record in Explore Bristol Research PDF-document This is the author accepted manuscript (AAM). The final published version (version of record) is available online via ACS at http://pubs.acs.org/doi/10.1021/acs.biochem.7b01032. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ 1 QM/MM Simulations Identify the Ring-Opening Mechanism of 2 Creatininase 3 4 Jitrayut Jitonnom*†, Jon I. Mujika‡, Marc W. van der Kamp‖,§, and Adrian J. 5 Mulholland§ 6 7 † Division of Chemistry, School of Science, University of Phayao, Phayao, 56000 Thailand 8 ‡ Kimika Fakultatea, Euskal Herriko Unibertsitatea UPV/EHU, and Donostia International 9 Physics Center (DIPC), P.K. 1072, 20080 Donostia, Euskadi, Spain 10 ‖ School of Biochemistry, Biomedical Sciences Building, University Walk, University of 11 Bristol, BS8 1TD, U.K. 12 § Centre for Computational Chemistry, School of Chemistry, University of Bristol, Bristol 13 BS8 1TS, U.K. 14 15 16 17 18 19 20 21 To whom correspondence should be addressed: J.J.: Tel: +66 (0) 5446 6666 ext.
    [Show full text]
  • Improved Thermostability of Creatinase from Alcaligenes Faecalis Through Non-Biased Phylogenetic Consensus-Guided Mutagenesis
    Improved thermostability of creatinase from Alcaligenes Faecalis through non-biased phylogenetic consensus-guided mutagenesis Xue Bai Institute of Biothermal Science and Technology, University of Shanghai for Science and Technology Daixi Li Institute of Biothermal Science and Technology, University of Shanghai for Science and Technology Fuqiang Ma CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences Xi Deng State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University School of Life Sciences and Biotechnology Manjie Luo Wuhan Hzymes Biotechnology Co., Ltd Yan Feng State Key Laboratory of Microbial Metabolism,Shanghai Jiao Tong University School of Life Sciences and Biotechnology Guangyu Yang ( [email protected] ) Shanghai Jiao Tong University School of Life Sciences and Biotechnology https://orcid.org/0000- 0002-2758-4312 Research Keywords: creatinase, thermostability, consensus approach, multiple sequence alignment, phylogenetic analysis Posted Date: August 2nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-49252/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/23 Version of Record: A version of this preprint was published on October 17th, 2020. See the published version at https://doi.org/10.1186/s12934-020-01451-9. Page 2/23 Abstract Enzymatic quantication of creatinine has become an essential method for clinical evaluation of renal function. Although creatinase (CR) is frequently used for this purpose, its poor thermostability severely limits industrial applications. Herein, we report a novel creatinase from Alcaligenes faecalis (afCR) with higher catalytic activity and lower KM value, than currently used creatinases.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur Et Al
    US 2012026.6329A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur et al. (43) Pub. Date: Oct. 18, 2012 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/10 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/24 (2006.01) CI2N 9/02 (2006.01) (75) Inventors: Eric J. Mathur, Carlsbad, CA CI2N 9/06 (2006.01) (US); Cathy Chang, San Marcos, CI2P 2L/02 (2006.01) CA (US) CI2O I/04 (2006.01) CI2N 9/96 (2006.01) (73) Assignee: BP Corporation North America CI2N 5/82 (2006.01) Inc., Houston, TX (US) CI2N 15/53 (2006.01) CI2N IS/54 (2006.01) CI2N 15/57 2006.O1 (22) Filed: Feb. 20, 2012 CI2N IS/60 308: Related U.S. Application Data EN f :08: (62) Division of application No. 1 1/817,403, filed on May AOIH 5/00 (2006.01) 7, 2008, now Pat. No. 8,119,385, filed as application AOIH 5/10 (2006.01) No. PCT/US2006/007642 on Mar. 3, 2006. C07K I4/00 (2006.01) CI2N IS/II (2006.01) (60) Provisional application No. 60/658,984, filed on Mar. AOIH I/06 (2006.01) 4, 2005. CI2N 15/63 (2006.01) Publication Classification (52) U.S. Cl. ................... 800/293; 435/320.1; 435/252.3: 435/325; 435/254.11: 435/254.2:435/348; (51) Int. Cl. 435/419; 435/195; 435/196; 435/198: 435/233; CI2N 15/52 (2006.01) 435/201:435/232; 435/208; 435/227; 435/193; CI2N 15/85 (2006.01) 435/200; 435/189: 435/191: 435/69.1; 435/34; CI2N 5/86 (2006.01) 435/188:536/23.2; 435/468; 800/298; 800/320; CI2N 15/867 (2006.01) 800/317.2: 800/317.4: 800/320.3: 800/306; CI2N 5/864 (2006.01) 800/312 800/320.2: 800/317.3; 800/322; CI2N 5/8 (2006.01) 800/320.1; 530/350, 536/23.1: 800/278; 800/294 CI2N I/2 (2006.01) CI2N 5/10 (2006.01) (57) ABSTRACT CI2N L/15 (2006.01) CI2N I/19 (2006.01) The invention provides polypeptides, including enzymes, CI2N 9/14 (2006.01) structural proteins and binding proteins, polynucleotides CI2N 9/16 (2006.01) encoding these polypeptides, and methods of making and CI2N 9/20 (2006.01) using these polynucleotides and polypeptides.
    [Show full text]